Pfg Advisors Abb Vie Inc. Transaction History

Pfg Advisors

$1.55 Billion
Q3 2024

A detailed history of Pfg Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Pfg Advisors holds 24,699 shares of ABBV stock, worth $4.37 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

24,699

Previous 25,971 4.9%

Holding current value

$4.37 Million

Previous $4.45 Million 9.5%

% of portfolio

0.31%

Previous 0.31%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $208,404 - $253,547	-1,272 Reduced 4.9%	24,699 $4.88 Million
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $155,718 - $181,844	1,006 Added 4.03%	25,971 $4.45 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $304,457 - $346,900	-1,905 Reduced 7.09%	24,965 $4.55 Million
Q4 2023 Jan 19, 2024	BUY	$137.6 - $154.97 $27,795 - $31,303	202 Added 0.76%	26,870 $4.16 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $410,655 - $475,394	-3,074 Reduced 10.34%	26,668 $3.98 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $362,812 - $451,496	2,738 Added 10.14%	29,742 $4.01 Million
Q1 2023 Apr 20, 2023	BUY	$144.61 - $166.54 $346,630 - $399,196	2,397 Added 9.74%	27,004 $4.3 Million
Q4 2022 Jan 27, 2023	BUY	$138.31 - $165.87 $805,517 - $966,026	5,824 Added 31.01%	24,607 $3.98 Million
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $13,823 - $15,854	-103 Reduced 0.55%	18,783 $2.52 Million
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $68,121 - $86,605	495 Added 2.69%	18,886 $2.89 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $132,903 - $164,896	-1,007 Reduced 5.19%	18,391 $2.98 Million
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $32,014 - $40,507	298 Added 1.56%	19,398 $2.63 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $95,972 - $108,943	902 Added 4.96%	19,100 $2.06 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $46,502 - $51,806	442 Added 2.49%	18,198 $2.05 Million
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $44,602 - $49,102	436 Added 2.52%	17,756 $1.92 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $49,098 - $66,288	610 Added 3.65%	17,320 $1.86 Million
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $89,002 - $104,459	-1,036 Reduced 5.84%	16,710 $1.46 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $34,704 - $46,439	473 Added 2.74%	17,746 $1.72 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $54,244 - $82,241	841 Added 5.12%	17,273 $1.45 Million
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $10,026 - $12,544	139 Added 0.85%	16,432 $1.47 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $27,522 - $33,089	437 Added 2.76%	16,293 $1.2 Million
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $162,213 - $207,346	2,469 Added 18.44%	15,856 $1.07 Million
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $81,228 - $95,601	-1,053 Reduced 7.29%	13,387 $1.06 Million
Q4 2018 Feb 19, 2019	BUY	$77.85 - $96.01 $190,498 - $234,936	2,447 Added 20.4%	14,440 $1.15 Million
Q4 2018 Jan 18, 2019	BUY	$77.85 - $96.01 $933,655 - $1.15 Million	11,993 New	11,993 $1.05 Million
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $348,436 - $412,278	-3,881 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$92.01 - $123.21 $8,004 - $10,719	87 Added 2.29%	3,881 $367,000
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $339,790 - $372,608	3,794	3,794 $367,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Advisors with notifications on news.

Account